“…Furthermore, the introduction of cyclosulfamide and Nsulfamoyloxazolidin-2-one into glucosamine structure can lead to interesting new chemical and pharmacological potentialities due to their biological activities with a broad application as synthetic intermediates (Bouzina et al, 2021;Nicolaou et al, 2004) especially in the asymmetric synthesis (F ecourt et al, 2010). They present a variety of interesting and useful properties that make them attractive as cyclic scaffolds for peptidomimetics in the design of protease inhibitors such as HIV protease (Hult en et al, 1999;Jadhav & Woerner, 1995;Schaal et al, 2001), serine protease (Groutas et al, 2001;He et al, 2000;Kuang et al, 2000;Yang et al, 2008), metalloprotease (Ducry et al, 1999), inhibitors of noroviruses (Dou et al, 2012), glycosidase inhibitors (Benltifa et al, 2008), and antibacterial activity (Abbaz et al, 2014;Bouzina et al, 2018).…”